Glycemic control was slightly better with lixisenatide: mean postbaseline difference, -0.27% (95% CI: -0.32 to -0.22)
Despite its effectiveness, many patients find long-term use difficult to tolerate
A BMI-23 policy means Eden will treat the woman whose scale says 28 but whose waist, blood pressure, and glucose say 35
Your provider will show you how to inject, store, and dispose of the medication safely after use
These sources were used to collect prescription statistics, regulatory approval data, clinical safety studies, epidemiological trends, and competitive landscape analysis for short-acting GLP-1 agonists, long-acting GLP-1 agonists, dual-action therapies, and emerging oral/inhalation formulations
levonorgestrel/ethinyl estradiolLevonorgestrel/ethinyl estradiol is a combination hormonal contraceptive (CHC) for use by women of reproductive potential to prevent pregnancy